PGY1 Pharmacy Fresno, California

This 52-week, ASHP-accredited PGY1 Pharmacy Residency Program will allow the Resident Pharmacist to become familiar with institutional pharmacy practice in an Integrated Healthcare System.

The purpose of the Kaiser Permanente, Fresno PGY1 Pharmacy Residency Program is to build on Doctor of Pharmacy education and outcomes to contribute to the development of clinical pharmacists responsible for medication-related care of patients with a wide range of conditions, eligible for board certification, and eligible for postgraduate year two (PGY2) pharmacy residency training.

---

Pharmacy Services

The Kaiser Permanente Fresno Medical Center Pharmacists provide direct patient care in a variety of clinical settings, including Acute Care (Inpatient Pharmacy Practice and Inpatient Internal Medicine), Adult Family Medicine, Cardiovascular Risk Program/PHASE (Preventing Heart Attacks and Strokes Everyday), Chronic Pain Management, Complex Chronic Conditions, Congestive Heart Failure, Medication Therapy Management, Memory Care, Oncology, and Transitional Care.

Our outpatient pharmacies are supported by a centralized, automated drug refilling pharmacy, a call processing center, and a Pharmacy Information Management System that is fully integrated with Kaiser Permanente’s electronic medical record, allowing our pharmacists to focus on patient counseling, drug therapy management and formulary management.

About Kaiser Permanente Fresno

---

Learning Experiences

Required Learning Experiences

• Orientation
• Cardiovascular Risk/PHASE (Preventing Heart Attacks and Strokes Everyday)
• Complex Chronic Conditions
• Extra Care Program
• Drug Use Management
• Inpatient Internal Medicine
• Medication Therapy Management
• Extra Care Program
• Chronic Pain Management
• Congestive Heart Failure

Required Longitudinal Learning Experiences

• Drug Information (no longer required if resident selects the Regional Drug Intelligence and Strategy elective)
• Inpatient Pharmacy Practice
• Pharmacy Practice Management
• Medicare Stars Adherence
• Residency Project

Elective Learning Experiences

• Adult Family Medicine
• Oncology
• Sterile Compounding
• Transitional Care Pharmacy
• Regional Pharmacy Continuum
• Regional Drug Intelligence and Strategy

---

Requirements for Acceptance

• Must be licensed as an Intern Pharmacist in the state of California by the first day of residency program.
• Resident must be a licensed California pharmacist within 120 days from the program start date. Residents who are not licensed as a pharmacist within 120 days from the program start date will have their term of appointment extended by the number of days the resident is without licensure past the 120-day deadline up to a maximum of 45 days. Failure to obtain a California state pharmacist license within 165 days from the program start date will result in the resident being dismissed from the program and employment will be terminated.
• To be eligible for pharmacist licensure, candidates must be graduates or candidates for graduation from an ACPE accredited degree program (or one in the process of pursuing accreditation) or have a Foreign Pharmacy Graduate Examination Committee (FPGEC) certificate from the NABP.
• For more information regarding licensing in California, please visit www.pharmacy.ca.gov
• Certifications (If applicable): BLS, ACLS
• Candidates must be registered in the National Matching Services, Inc. (NMS).
• Candidates must participate in the ASHP Matching Program.
• Program NMS Code: 170413 and ASHP Program Code: 92016

---

Application Requirements

• Statement of Interest/Letter of Intent
• Curriculum Vitae
• Official Pharmacy School transcripts, sent directly from the applicant’s college or school of pharmacy
• Three letters of references/recommendations utilizing the form in PhORCAS
• Application Deadline: January 2, 2025

---

Interview Details

• On-Site Interview (unless otherwise indicated for health & safety reasons)
• Participation in a panel interview.
• Click here to link to the Virtual Information Session: 
  • November 6, 2024 – 12p.m. – 1p.m. PST

**This residency agrees that no person at this residency will solicit, accept, or use any ranking-related information from any residency applicant**

Back to all programs